logo-loader
Canopy Growth Corporation

Canopy Growth pours C$30M into Canopy Rivers

'By increasing Canopy Growth's investment in Canopy Rivers, we are demonstrating our interest in growing great companies,' said CEO Bruce Linton

baseball cap filled with dollars
The investment is expected to close on or around February 27

Canopy Growth (TSE:WEED) NYSE:CGC) said Thursday that it intends to increase its total investment in its investing arm Canopy Rivers Inc (OTCMKTS:CNPOF) by C$30 million.

The investment by the Canadian cannabis company will be made via a private placement of subordinated voting shares in the capital of Canopy Rivers in parallel with Canopy Rivers bought deal offering of subordinate voting shares.

After the closing of the deal, Canopy Growth will increase its ownership of Canopy Rivers shares to 27.3% from about 26.5%.

READ: Canopy Growth stock climbs after Piper Jaffray raises price target to $60 from $40

"The advantage of a strengthened Canopy Rivers/Canopy Growth relationship is that it accelerates and de-risks execution for invested companies," said Bruce Linton, Canopy Growth's founder and co-CEO, in a statement.

"By increasing Canopy Growth's investment in Canopy Rivers, we are demonstrating our interest in growing great companies, developing selective opportunities and delivering Canopy's shareholders more growth," added Linton.

The investment is being co-led by CIBC Capital Markets and is expected to close on or around February 27.

New York-based beverage group Constellation Brands Inc (NYSE:STZ) last year invested $4 billion into Canopy, raising its stake to 37% as it becomes bullish on the future of the cannabis industry.

Canopy Growth shares held steady at $46.66 in afternoon trade on Thursday while Canopy Rivers stock slipped 1.92% to $3.57.

Contact Ellen Kelleher at [email protected]

Quick facts: Canopy Growth Corporation

Price: $37.25

Market: TSX
Market Cap: $12.65 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

2 days, 14 hours ago

2 min read